FC2 Female Condom Brings "Overdue Advice" Event to NYC's Union Square for Global Female Condom Day
NEW YORK, Sept. 15, 2026 /PRNewswire/ -- Clear Future's FC2 Female Condom holds a first-of-its-kind event to celebrate Global Female Condom Day in Manhattan's Union Square. On Sept 15, 2026 from 11am to 4pm, FC2's "Overdue Advice" event brings reproductive health professionals to Union Square's south plaza to educate New Yorkers about the female (internal) condom and invites them to share the advice they think is long overdue - whether about protection, their bodies, or anything else.
Event partners include the NYC Department of Health and Mental Hygiene, as well as community health organizations Iris House, Destination Tomorrow, Voces Latinas, Housing Works, Alliance for Change, and AIDS Healthcare Foundation, which will provide information about how to access sexual health services in the city. Among the services provided will be FC2 demonstrations and on-site HIV and HPV testing.
"We're proud to be working with the New York City Department of Health and Mental Hygiene, which is an indispensable part of the city's infrastructure – one that keeps New Yorkers healthy by ensuring access to safe and effective birth control and STI prevention methods," said Michael Kuznetsov, CEO of Clear Future, manufacturer of the FC2 Female Condom.
Through the NYC Condom Availability Program, the NYC Health Department makes safe sex products available to thousands of businesses, community-based organizations, and health clinics throughout the city. Businesses and other organizations in NYC interested in distributing safer sex products can request FC2 Female Condoms through the NYC Safer Sex Portal, supplies permitting.
FC2 is distributed through public health organizations nationwide and is also fully covered, with no co-pay or deductible, by most health insurance with a prescription. Clinicians choose to prescribe FC2 to patients who need nonhormonal protection and consideration of latex allergy, vaginal dryness, backup contraception during initiation and dose escalation of certain GLP-1 medications, or who need a barrier method that doesn't require an erection to fit to wear. FC2 is hormone-free, latex-free, and regularly tested for contamination from BPA and PFAS chemicals regulated in the EU.
For important safety information, or to get an online prescription for FC2, visit fc2condoms.com
About Clear Future
Clear Future manufactures FC2 Female Condom, the only FDA-approved internal condom indicated for preventing pregnancy and reducing the risk of HIV/AIDS and other STIs. With hundreds of millions of FC2 distributed around the globe, FC2 has become the preferred alternative to the external condom for countless partners worldwide. FC2 Female Condom is a registered trademark of Clear Future, Inc.
Media Contact:
Claire Marks
1.800.274.6601
SOURCE Clear Future, Inc.
Share this article